Cue-induced cravings for cigarettes

Current Cardiovascular Risk Reports

Volumn 3, Issue 6, 2009, Pages 385-390

  Ferguson, Stuart G ^a   Shiffman, Saul ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873498323     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0057-0     Document Type: Review

References (51)

1. Sayette MA, Shiffman S, Tiffany ST, et al.: The measurement of drug craving. Addiction 2000, 95: 189-210.
2. Ferguson SG, Shiffman S, Gwaltney CJ: Does reducing withdrawal severity mediate nicotine patch efficacy- A randomized clinical trial. J Consult Clin Psychol 2006, 74: 1153-1161.
3. Killen JD, Fortmann SP: Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 1997, 5: 137-142.
4. Shiffman S, Engberg JB, Paty JA, et al.: A day at a time: predicting smoking lapse from daily urge. J Abnormal Psychol 1997, 106: 104-116.
5. West R, Hajek P, Belcher M: Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychologic Med 1989, 19: 981-985.
6. Breese CR, Marks MJ, Logel J, et al.: Effect of smoking history on [3H]nicotine binding in human postmortem brainJ Pharmacol Exp Ther 1997, 282: 7-13.
7. Jarvik ME, Madsen DC, Olmstead RE, et al.: Nicotine blood levels and subjective craving for cigarettes. Pharmacol Biochem Behav 2000, 66: 553-558.
8. Shiffman S, Gwaltney CJ, Balabanis MH, et al.: Immediate antecedents of cigarette smoking: an analysis from eco logical momentary assessment. J Abnorm Psychol 2002, 111: 531-545.
9. Tiffany S: A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychologic Rev 1990, 97: 147-168.
10. Bliss RE, Garvey AJ, Heinold JW, Hitchcock JL: The influence of situation and coping on relapse crisis outcomes after smoking cessation. J Consult Clin Psychol 1989, 57: 443-449.
11. Curry S, Marlatt GA: Strategies for coping with temptations to smoke. In Coping and Substance Abuse. Edited by Shiffman S, Wills TA. New York: Academic Press; 1985: 243-265.
12. Marlatt GA, Gordon JR: Relapse Prevention. New York, NY: Guilford Press; 1985.
13. Niaura RS, Rohsenow DJ, Binkoff JA, et al.: Relevance of cue reactivity to understanding alcohol and smoking relapse. J Abnorm Psychol 1988, 97: 133-152.
14. Shiffman S: Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 1982, 50: 71-86.
15. Abrams DB, Monti PM, Carey KB, et al.: Reactivity to smoking cues and relapse: two studies of discriminant validity. Behav Res Ther 1988, 26: 225-233.
16. Bordnick PS, Traylor A, Copp HL, et al.: Assessing reactivity to virtual reality alcohol based cues. Addict Behav 2008, 33: 743-756.
17. Carter BL, Tiffany ST: Meta-analysis of cue-reactivity in addiction research. Addiction 1999, 94: 327-340.
18. Sayette MA, Martin CS, Wertz JM, et al.: A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction 2001, 96: 1419-1432.
19. Baumann SB, Sayette MA: Smoking cues in a virtual world provoke craving in cigarette smokers. Psychol Addict Behav 2006, 20: 484-489.
20. Carter BL, Tiffany ST: The cue-availability paradigm: the effects of cigarette availability on cue reactivity in smokers. Exp Clin Psychopharmacol 2001, 9: 183-190.
21. Little M, Franken IH, van Strien JW: Changes in the electroencephalographic spectrum in response to smoking cues in smokers and ex-smokers. Neuropsychobiology 2009, 59: 43-50.
22. Tong C, Bovbjerg DH, Erblich J: Smoking-related videos for use in cue-induced craving paradigms. Addict Behav 2007, 32: 3034-3044.
23. Warren CA, McDonough BE: Event-related brain potentials as indicators of smoking cue-reactivity. Clin Neurophysiol 1999, 110: 1570-1584.
24. Wilson SJ, Sayette MA, Fiez JA: Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci 2004, 7: 211-214.
25. Zhang X, Chen X, Yu Y, et al.: Masked smoking-related images modulate brain activity in smokers. Hum Brain Mapping 2008, 30: 896-907.
26. Shiffman S, Paty JA, Gnys M, et al.: First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol 1996, 64: 366-379.
27. Niaura R, Abrams DB, Shadel WG, et al.: Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction 1999, 94: 685-695.
28. Shiffman S: Smoking cessation treatment: any progress?J Consult Clin Psychol 1993, 61: 718-722.
29. O'Brien CP, Childress AR, McClellan T, Ehrman R: Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addict Behav 1990, 15: 355-365.
30. Thewissen R, van den Hout M, Havermans RC, Jansen A. Context-dependency of cue-elicited urge to smoke. Addiction 2005, 100: 387-396.
31. Conklin CA, Tiffany ST: Applying extinction research and theory to cue-exposure addiction treatments. Addiction 2002, 97: 155-167.
32. Havermans RC, Jansen AT: Increasing the efficacy of cue exposure treatment in preventing relapse of addictive behavior. Addict Behav 2003, 28: 989-994.
33. Shiffman S: Coping with temptations to smoke. J Consult Clin Psychol 1984, 52: 261-267.
34. O'Connell KA, Hosein VL, Schwartz JE, Leibowitz RQ: How does coping help people resist lapses during smoking cessation?Health Psychol 2007, 26: 77-84.
35. Fiore MC, Jaen CR, Baker TB, et al.: Treating Tobacco Use and Dependence. 2008 Update. Clinical practice guideline. Rockville, MD: U. S. Department of Health and Human Services; 2008.
36. Hussain S, Zawertailo L, Zack M, et al.: The impact of bupropion on cue-reactivity and the subjective effects of smoking in ad lib smokers. Presented at the Annual meeting of the Society for Research on Nicotine & Tobacco. Austin, TX; February 21-24, 2007.
37. Brody AL, Mandelkern MA, Lee G, et al.: Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res 2004, 130: 269-281.
38. Ferguson SG, Shiffman S: The relevance and treatment of cue-induced cravings in tobacco dependence. J Substance Abuse Treat 2009, 36: 235-243.
39. Niaura R, Hitsman B, Shadel W, et al.: Effects of Varenicline on cue-provoked cigarette craving and acute nicotine withdrawal. Presented at the Annual meeting of the Society for Research on Nicotine & Tobacco. Austin, TX; February 21-24, 2007.
40. Stead LF, Perera R, Bullen C, et al.: Nicotine replacement therapy for smoking cessation. Cochrane Database Systematic Rev 2008, CD000146.
41. Fant RV, Owen LL, Henningfield JE: Nicotine replacement therapy. Primary Care 1999, 26: 633-652.
42. Tiffany ST, Cox LS, Elash CA: Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 2000, 68: 233-240.
43. Havermans RC, Debaere S, Smulders FT, et al.: Effect of cue exposure, urge to smoke, and nicotine deprivation on cognitive performance in smokers. Psychol Addict Behav 2003, 17: 336-339.
44. Morissette SB, Palfai TP, Gulliver SB, et al.: Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers. Psychol Addict Behav 2005, 19: 192-198.
45. Waters AJ, Shiffman S, Sayette MA, et al.: Cue-provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol 2004, 72: 1136-1143.
46. Rohsenow DJ, Monti PM, Hutchison KE, et al.: High-dose transdermal nicotine and naltrexone: Effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol 2007, 15: 81-92.
47. Shiffman S, Elash CA, Paton SM, et al.: Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction 2000, 95: 1185-1195.
48. Shiffman S, Shadel WG, Niaura R, et al.: Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berlin) 2003, 166: 34-350.
49. Niaura R, Sayette M, Shiffman S, et al.: Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction 2005, 100: 1720-1730.
50. Durcan MJ, De'Ath J, Targett D, et al.: Efficacy of the nicotine lozenge in relieving cue provoked cravings. Presented at the Annual European meeting of the Society for Research on Nicotine & Tobacco. Padua, Italy; November 20-22, 2003.
51. Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO: Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clin Pharmacokinet 1996, 31: 65-80.